NEW YORK (GenomeWeb News) – Affymetrix and Nanosphere were the two greatest beneficiaries of a rebound in March for stocks in the GenomeWeb Daily News Index.

Shares of both firms gained just over 50 percent in March, as stocks across the board rebounded from a very poor February, in which the Index had dropped 6 percent and the Dow Jones Industrial Average had fallen 12 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.